Skip to content

Eda Zhuleku



Zhuleku Eda
Eda Zhuleku



Eda is a life sciences specialist lawyer with more than nine years’ experience in the sector.

Eda is an expert with respect to all regulatory issues that may be of interest to pharma, medical device; IVDs and life science businesses, including (early) benefit assessment, market access strategies, prescription of drugs and medical devices and eligibility for reimbursement. Further, she assists in every stage of the product life-cycle and advises pharma businesses, medical device and other life sciences businesses on challenges in terms of reimbursement and social law.

Related articles

Lab worker using syringe

Blog Post: 01 February 2023

Clinical Trial Regulation: Balancing Transparency Requirements and Protection of CCI – new Q&A published

The Clinical Trial Regulation (EU) No 536/2014 (CTR) became fully applicable yesterday (31 January), following the end of the transition period. Therefore, the use of the Clinical Trial Information…

Read more

Blog Post: 15 December 2022

European Commission proposes to extend MDR transition periods to prevent shortages in medical devices

Read more

Blog Post: 28 November 2022

Webinar - EU developments in pricing and reimbursement

Read more

News: 07 October 2022

Allen & Overy`s Life Sciences team advises Vision Healthcare on the acquisition of AixSwiss

Read more



Corporate and M&A


Life Sciences



Maximilianstraße 35
80539 Munich

View office →



Certified Lawyer for Life Sciences since 2018

Pro-bono experience

  • Eda is a member of the Pro Bono Steering Committee in Germany

Published work

  • Zhuleku E. (2020) “Covid-19 and the Life Science Sector „Covid-19 and the Life Science Sector”, Practical Law ‐ London, Thomson Reuters
  • Zhuleku E, Professor Ehlers A, (2018) „Neues Bundesdatenschutzgesetz und EU‐Datenschutzverordnung Anpassungsbedarf bei den Unternehmen“ in pharmind Nr. 1, 82 , Edition Cantor Verlag
  • Zhuleku E, Professor Ehlers A, (2016) „Die FSA‐Kodizes und ihre Durchsetzung – wie konsequent ist das“ in: pharmind Nr. 6, 869, Edition Cantor Verlag
  • Zhuleku E, (2014) Die ärztliche Aufklärungspflicht nach dem Patientenrechtegesetz“ in: Der Diabetologe, Springer Medizin
  • Zhuleku E, (2013) „Rechtliche Stolpersteine des Bestandsmarktaufrufs“ in Highlights Magazin Ausgabe 8/13, Lehr & Visarius Verlag GmbH